These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Options when HIV treatments fail. Treat Rev; 1998; (No 28):7-9. PubMed ID: 11365426 [TBL] [Abstract][Full Text] [Related]
31. A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection. Wolbach J; Capoccia K Nurse Pract; 1999 Jun; 24(6):81-2, 87-90, 92. PubMed ID: 10431297 [No Abstract] [Full Text] [Related]
32. Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase. Kagan RM; Lee TS; Ross L; Lloyd RM; Lewinski MA; Potts SJ Antiviral Res; 2007 Sep; 75(3):210-8. PubMed ID: 17442410 [TBL] [Abstract][Full Text] [Related]
33. Non-nucleoside reverse transcriptase inhibitors--an overview. Bell C; Matthews GV; Nelson MR Int J STD AIDS; 2003 Feb; 14(2):71-7. PubMed ID: 12662384 [No Abstract] [Full Text] [Related]
34. The role of NNRTIs in antiretroviral combination therapy: an introduction. Nelson M Int J STD AIDS; 2001 Nov; 12 Suppl 4():1-2. PubMed ID: 11589821 [TBL] [Abstract][Full Text] [Related]
35. [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection]. van Leth F; Lange JM Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1719-22. PubMed ID: 16924943 [TBL] [Abstract][Full Text] [Related]
36. [CROI--presentation of new study results. In a comparison of NNRTI nevirapine is equally effective]. MMW Fortschr Med; 2004 Apr; 146 Spec No 1():91. PubMed ID: 15373068 [No Abstract] [Full Text] [Related]
39. Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs. Li D; Zhan P; Liu H; Pannecouque C; Balzarini J; De Clercq E; Liu X Bioorg Med Chem; 2013 Apr; 21(7):2128-34. PubMed ID: 23415090 [TBL] [Abstract][Full Text] [Related]